Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 06, 2021 Filed Aug 10, 2021 20:05 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
Tax withholdingCommon Stock | 9,225 | $82.61 | $762,077.25 |
DisclosureSEC source: 0001179110-21-008078 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,400,244 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 20:03 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Tax withholdingCommon Stock | 2,978 | $82.61 | $246,012.58 |
DisclosureSEC source: 0001179110-21-008076 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,407 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:20 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 37,048 | $0.00 Strike: $89.45 | $0.00 |
DisclosureSEC source: 0001179110-21-008034 · edgar.xml · derivative · entry 8 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,048 Underlying: Common Stock · 37,048 shares Expires 2026-08-05 F3 · derivative.exercise_date: The stock option granted to the Reporting Person on August 5, 2021 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:20 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
GrantCommon Stock | 29,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008034 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,409,469 F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 5, 2021 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:18 UTC |
Herman Gerald NVice President, CFO
|
GrantStock Option (Right to Buy) · Derivative | 9,818 | $0.00 Strike: $81.32 | $0.00 |
DisclosureSEC source: 0001179110-21-008033 · edgar.xml · derivative · entry 2 Herman Gerald N · CIK 0001327294 · Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,818 Underlying: Common Stock · 9,818 shares Expires 2031-08-05 F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 5, 2021 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:18 UTC |
Herman Gerald NVice President, CFO
|
GrantCommon Stock | 7,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008033 · edgar.xml · nonDerivative · entry 1 Herman Gerald N · CIK 0001327294 · Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,183 F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 5, 2021 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:16 UTC |
Busse FalkoPresident, BioSpin Group
|
GrantStock Option (Right to Buy) · Derivative | 4,153 | $0.00 Strike: $81.32 | $0.00 |
DisclosureSEC source: 0001179110-21-008032 · edgar.xml · derivative · entry 2 Busse Falko · CIK 0001739999 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,153 Underlying: Common Stock · 4,153 shares Expires 2031-08-05 F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 5, 2021 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:16 UTC |
Busse FalkoPresident, BioSpin Group
|
GrantCommon Stock | 3,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008032 · edgar.xml · nonDerivative · entry 1 Busse Falko · CIK 0001739999 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,675 F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 5, 2021 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:15 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
GrantStock Option (Right to Buy) · Derivative | 11,821 | $0.00 Strike: $81.32 | $0.00 |
DisclosureSEC source: 0001179110-21-008031 · edgar.xml · derivative · entry 2 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,821 Underlying: Common Stock · 11,821 shares Expires 2031-08-05 F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 5, 2021 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:15 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
GrantCommon Stock | 9,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008031 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,385 F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 5, 2021 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:13 UTC |
Srega JuergenGroup President Bruker CALID
|
GrantStock Option (Right to Buy) · Derivative | 14,534 | $0.00 Strike: $81.32 | $0.00 |
DisclosureSEC source: 0001179110-21-008030 · edgar.xml · derivative · entry 2 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,534 Underlying: Common Stock · 14,534 shares Expires 2031-08-05 F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 5, 2021 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:13 UTC |
Srega JuergenGroup President Bruker CALID
|
GrantCommon Stock | 11,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008030 · edgar.xml · nonDerivative · entry 1 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,877 F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 5, 2021 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:10 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
GrantStock Option (Right to Buy) · Derivative | 2,258 | $0.00 Strike: $81.32 | $0.00 |
DisclosureSEC source: 0001179110-21-008029 · edgar.xml · derivative · entry 2 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,258 Underlying: Common Stock · 2,258 shares Expires 2031-08-05 F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 5, 2021 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:10 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
GrantCommon Stock | 1,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008029 · edgar.xml · nonDerivative · entry 1 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,123 F1 · shares: The Restricted Stock Units granted to the Reporting Person on August 5, 2021 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| March 22, 2021 Filed Mar 23, 2021 20:28 UTC |
Friend Cynthia MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 800 | $0.00 Strike: $26.17 | $0.00 |
DisclosureSEC source: 0001179110-21-003717 · edgar.xml · derivative · entry 3 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 800 shares Expires 2026-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three approximately equal annual installments on May 20, 2017, 2018 and 2019. Read SEC document |
| March 22, 2021 Filed Mar 23, 2021 20:28 UTC |
Friend Cynthia MDirector
|
SaleCommon Stock | 1,800 | $60.43 | $108,765.54 |
DisclosureSEC source: 0001179110-21-003717 · edgar.xml · nonDerivative · entry 2 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,686 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.87 to $60.78, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 22, 2021 Filed Mar 23, 2021 20:28 UTC |
Friend Cynthia MDirector
|
Exercise / conversionCommon Stock | 800 | $26.17 | $20,936.00 |
DisclosureSEC source: 0001179110-21-003717 · edgar.xml · nonDerivative · entry 1 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2021 Filed Jan 7, 2021 21:44 UTC |
Kastner Marc ADirector
|
SaleCommon Stock | 1,236 | $56.56 | $69,908.16 |
DisclosureSEC source: 0001179110-21-000410 · edgar.xml · nonDerivative · entry 1 Kastner Marc A · CIK 0001570183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,146 F1 · shares: These shares were disposed of in an open market sale pursuant to a 10b5-1 trading plan Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:15 UTC |
ROSENTHAL BOBDirector
|
GrantCommon Stock | 2,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000401 · edgar.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,959 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2022. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:14 UTC |
Requardt Hermann FritzDirector
|
GrantCommon Stock | 2,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000400 · edgar.xml · nonDerivative · entry 1 Requardt Hermann Fritz · CIK 0001651105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,959 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2022. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:14 UTC |
Perkins Adelene QDirector
|
GrantCommon Stock | 2,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000399 · edgar.xml · nonDerivative · entry 1 Perkins Adelene Q · CIK 0001375124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,138 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2022. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:13 UTC |
PACKER RICHARD ADirector
|
GrantCommon Stock | 2,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000398 · edgar.xml · nonDerivative · entry 1 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,066 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2022. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:12 UTC |
ORNELL JOHN ADirector
|
GrantCommon Stock | 2,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000397 · edgar.xml · nonDerivative · entry 1 ORNELL JOHN A · CIK 0001186875 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,959 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2022. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:08 UTC |
LINTON WILLIAM ADirector
|
GrantCommon Stock | 2,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000396 · edgar.xml · nonDerivative · entry 1 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,709 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2022. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:07 UTC |
Kastner Marc ADirector
|
GrantCommon Stock | 2,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000395 · edgar.xml · nonDerivative · entry 1 Kastner Marc A · CIK 0001570183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,382 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2022. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:03 UTC |
Friend Cynthia MDirector
|
GrantCommon Stock | 2,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000394 · edgar.xml · nonDerivative · entry 1 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,686 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2022. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:02 UTC |
Anderson Bonnie HDirector
|
GrantCommon Stock | 2,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-000393 · edgar.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,841 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2022. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:00 UTC |
Friend Cynthia MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 800 | $0.00 Strike: $26.17 | $0.00 |
DisclosureSEC source: 0001179110-20-012177 · edgar.xml · derivative · entry 3 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 800 shares Expires 2026-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three approximately equal annual installments on May 20, 2017, 2018 and 2019. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:00 UTC |
Friend Cynthia MDirector
|
SaleCommon Stock | 1,800 | $54.32 | $97,776.00 |
DisclosureSEC source: 0001179110-20-012177 · edgar.xml · nonDerivative · entry 2 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,384 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 21, 2020 Filed Dec 22, 2020 21:00 UTC |
Friend Cynthia MDirector
|
Exercise / conversionCommon Stock | 800 | $26.17 | $20,936.00 |
DisclosureSEC source: 0001179110-20-012177 · edgar.xml · nonDerivative · entry 1 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 21:50 UTC |
Friend Cynthia MDirector
|
SaleCommon Stock | 3,473 | $54.95 | $190,841.35 |
DisclosureSEC source: 0001179110-20-012001 · edgar.xml · nonDerivative · entry 1 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,384 Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 21:01 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 5,000 | $0.00 Strike: $22.19 | $0.00 |
DisclosureSEC source: 0001179110-20-011031 · edgar.xml · derivative · entry 3 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2026-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in four approximately equal annual installments on October 04, 2017, 2018, 2019 and 2020. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 21:01 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
SaleCommon Stock | 5,000 | $47.93 | $239,650.00 |
DisclosureSEC source: 0001179110-20-011031 · edgar.xml · nonDerivative · entry 2 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,317 Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 21:01 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionCommon Stock | 5,000 | $22.19 | $110,950.00 |
DisclosureSEC source: 0001179110-20-011031 · edgar.xml · nonDerivative · entry 1 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 16:44 UTC |
LINTON WILLIAM ADirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 6,000 | $0.00 Strike: $16.09 | $0.00 |
DisclosureSEC source: 0001179110-20-010955 · edgar.xml · derivative · entry 2 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in three approximately equal annual installments on January 05, 2012, 2013 and 2014. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 16:44 UTC |
LINTON WILLIAM ADirector
|
Exercise / conversionCommon Stock | 6,000 | $16.09 | $96,540.00 |
DisclosureSEC source: 0001179110-20-010955 · edgar.xml · nonDerivative · entry 1 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2020 Filed Oct 6, 2020 14:36 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Tax withholdingCommon Stock | 1,649 | $38.78 | $63,948.22 |
DisclosureSEC source: 0001179110-20-010294 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,304 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| September 21, 2020 Filed Sep 21, 2020 21:55 UTC |
Friend Cynthia MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 800 | $0.00 Strike: $26.17 | $0.00 |
DisclosureSEC source: 0001179110-20-009902 · edgar.xml · derivative · entry 3 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 800 shares Expires 2026-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in three approximately equal annual installments on May 20, 2017, 2018 and 2019. Read SEC document |
| September 21, 2020 Filed Sep 21, 2020 21:55 UTC |
Friend Cynthia MDirector
|
SaleCommon Stock | 800 | $37.58 | $30,065.04 |
DisclosureSEC source: 0001179110-20-009902 · edgar.xml · nonDerivative · entry 2 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,857 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $37.79, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 21, 2020 Filed Sep 21, 2020 21:55 UTC |
Friend Cynthia MDirector
|
Exercise / conversionCommon Stock | 800 | $26.17 | $20,936.00 |
DisclosureSEC source: 0001179110-20-009902 · edgar.xml · nonDerivative · entry 1 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 18:04 UTC |
Anderson Bonnie HDirector
|
GrantCommon Stock | 1,539 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-009617 · edgar.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,539 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing September 3, 2021. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 19:24 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Tax withholdingCommon Stock | 7,916 | $44.33 | $350,916.28 |
DisclosureSEC source: 0001179110-20-008944 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,953 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 18:09 UTC |
Srega JuergenGroup President Bruker CALID
|
GrantStock Option (Right to Buy) · Derivative | 24,478 | $0.00 Strike: $43.50 | $0.00 |
DisclosureSEC source: 0001179110-20-008827 · edgar.xml · derivative · entry 2 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,478 Underlying: Common Stock · 24,478 shares Expires 2030-08-06 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 6, 2021. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 18:09 UTC |
Srega JuergenGroup President Bruker CALID
|
GrantCommon Stock | 21,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-008827 · edgar.xml · nonDerivative · entry 1 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,255 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 6, 2021. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 18:09 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
GrantStock Option (Right to Buy) · Derivative | 3,693 | $0.00 Strike: $43.50 | $0.00 |
DisclosureSEC source: 0001179110-20-008826 · edgar.xml · derivative · entry 2 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,693 Underlying: Common Stock · 3,693 shares Expires 2030-08-06 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 6, 2021. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 18:09 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
GrantCommon Stock | 3,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-008826 · edgar.xml · nonDerivative · entry 1 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,317 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 6, 2021. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 18:09 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
GrantStock Option (Right to Buy) · Derivative | 19,329 | $0.00 Strike: $43.50 | $0.00 |
DisclosureSEC source: 0001179110-20-008825 · edgar.xml · derivative · entry 2 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,329 Underlying: Common Stock · 19,329 shares Expires 2030-08-06 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 6, 2021. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 18:09 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
GrantCommon Stock | 17,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-008825 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,869 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 6, 2021. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 18:08 UTC |
Busse FalkoPresident, BioSpin Group
|
GrantStock Option (Right to Buy) · Derivative | 5,828 | $0.00 Strike: $43.50 | $0.00 |
DisclosureSEC source: 0001179110-20-008823 · edgar.xml · derivative · entry 2 Busse Falko · CIK 0001739999 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,828 Underlying: Common Stock · 5,828 shares Expires 2030-08-06 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing August 6, 2021. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 18:08 UTC |
Busse FalkoPresident, BioSpin Group
|
GrantCommon Stock | 5,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-008823 · edgar.xml · nonDerivative · entry 1 Busse Falko · CIK 0001739999 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,354 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing August 6, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.